Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2005 Jun 30:5:67.
doi: 10.1186/1471-2407-5-67.

Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma

Affiliations
Case Reports

Acute hepatic failure and multi-system organ failure secondary to replacement of the liver with metastatic melanoma

Gilaad G Kaplan et al. BMC Cancer. .

Abstract

Background: Metastatic malignant melanoma to the liver resulting in fulminant hepatic failure is a rare occurrence.

Case presentation: A 46 year old man presented to hospital with massive hepatomegaly, elevated liver enzymes and increased lactate three weeks following resection of a malignant melanoma from his shoulder (Clark level 5). Initially stable, he decompensated 24 to 48 hours subsequent to presentation with respiratory failure requiring mechanical ventilation, distributive shock requiring high dose vasopressor infusion, coagulopathy refractory to plasma infusion, progressive rise in liver enzymes and severe metabolic abnormalities including hyperkalemia, acidosis, hyperphosphatemia, hyperuricemia and hypocalcemia. Refractory to aggressive physiologic support he received palliation. Autopsy revealed >80% liver infiltration by metastatic malignant melanoma.

Conclusion: We report a case of fulminant hepatic failure secondary to metastatic malignant melanoma infiltration of the liver.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Liver biopsy contains numerous neoplastic elongate cells consistent with malignant melanoma infiltration.
Figure 2
Figure 2
Immunohistochemistry of the liver. S-100 antibody stains malignant melanocytes with a brown chromogen (diaminobenzidine). Rare negative cells (blue due to hematoxylin counterstaining) are intact hepatocytes.

References

    1. Desmond RA, Soong SJ. Epidemiology of malignant melanoma. Surg Clin North Am. 2003;83:1–29. doi: 10.1016/S0039-6109(02)00092-0. - DOI - PubMed
    1. Te HS, Schiano TD, Kahaleh M, Lissoos TW, Baker AL, Hart J, Conjeevaram HS. Fulminant hepatic failure secondary to malignant melanoma: Case report and review of the literature. American Journal of Gastroenterology. 1999;94:262–266. doi: 10.1111/j.1572-0241.1999.00811.x. - DOI - PubMed
    1. Montero JL, Muntane J, Heras S, Ortega R, Fraga E, De lat Mata M. Acute liver failure cause by diffuse hepatic melanoma infiltration. Journal of Hepatology. 2002;37:540–541. doi: 10.1016/S0168-8278(02)00219-2. - DOI - PubMed
    1. Bouloux PMG, Scott RJ, Goligher JE, Kindell C. Fulminant hepatic failure secondary to diffuse liver infiltration by melanoma. The Royal Society of Medicine. 1986;79:302–303. - PMC - PubMed
    1. Misuzu T, Watanabe S, Masaki T, Kurokohchi K, Kinekawa F, Inoue H, Uchida N, Kuriyama S. Fulimnant hepatic failure caused by malignant melanoma of unknown primary origin. J Gastroenterol. 2004;39:804–806. - PubMed

Publication types